JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB191606

Anti-PI 3 Kinase p85 alpha 抗体 [EPR18702]

Anti-PI 3 Kinase p85 alpha antibody [EPR18702]

5

(2 Reviews)

|

(388 Publications)

Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) is a rabbit monoclonal antibody detecting PI 3 Kinase p85 alpha in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF. Suitable for African green monkey, Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 220 publications

別名を表示する

GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha

12 Images
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma cell line) cells labeling PI3K p85 with ab191606 at 1/250 dilution, followed by Goat Anti-Rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on HepG2 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191606 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Overlay histogram showing HepG2 cells fixed in 4% PFA and stained with ab191606 at a dilution of 1/80 (red line). The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit at a dilution of 1/500. Rabbit monoclonal IgG (ab172730)was used as an isotype control (black line) and cells incubated in the absence of both primary and secondary antibody were used as a negative control (blue line).

Immunoprecipitation - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • IP

Supplier Data

Immunoprecipitation - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

PI3K p85 was immunoprecipitated from 1mg of MCF7 (Human breast adenocarcinoma cell line) whole cell lysate with ab191606 at 1/50 dilution. Western blot was performed from the immunoprecipitate using ab191606 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : MCF7 whole cell lysate, 10μg (Input).

Lane 2 : ab191606 IP in MCF7 whole cell lysate.

Lane 3 : Rabbit IgG, monoclonal - Isotype Control (ab172730) instead of ab191606 in MCF7 whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 5 seconds.

All lanes:

Immunoprecipitation - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606)

Predicted band size: 83 kDa

false

Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 100% Methanol permeabilized NIH/3T3 (Mouse embryonic fibroblast cell line) cells labeling PI3K p85 with ab191606 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic staining on NIH/3T3 cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody - Loading Control (ab7291) at 1/1000 dilution and Goat Anti-Mouse IgG (AlexaFluor®594) preadsorbed (ab150120) at 1/1000 dilution (red).
The negative controls are as follows :
-ve control 1 : ab191606 at 1/500 dilution followed by ab150120 at 1/1000 dilution.
-ve control 2 : ab7291 at 1/1000 dilution followed by ab150077 at 1/1000 dilution.

Flow Cytometry (Intracellular) - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed NIH/3T3 (Mouse embryonic fibroblast cell line) cells labeling PI3K p85 with ab191606 at 1/150 dilution (red) compared with a Rabbit IgG,monoclonal -Isotype control (ab172730) (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat anti Rabbit IgG (Alexa Fluorr® 488) at 1/500 dilution was used as the secondary antibody.

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Lab

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.

Compared with ab40755, ab191606 has higher sensitivity. We recommend ab124805 as an alternative for testing western blot.

We suggest optimizing experimental protocols (increasing lysate amount, using lower dilution or higher sensitivity ECL substrate) to improve results when using ab197896 in western blot.

Lane 1:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] (<a href='/products/primary-antibodies/pi-3-kinase-p85-alpha-antibody-ep380y-ab40755'>ab40755</a>) at 1/1000 dilution

Lane 2:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution

All lanes:

Jurkat (human T cell leukemia T lymphocyte) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Observed band size: 85 kDa

false

Exposure time: 40s

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Supplier Data

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1 and 2 : 10 seconds; Lane 3 and 4 : 3 seconds.

The molecular weight observed is consistent with what have been described in the literatures (PMID : 8921377, 12649157).

All lanes:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution

Lane 1:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg

Lane 3:

Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg

Lane 4:

Raji (Human Burkitt's lymphoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 83 kDa

Observed band size: 46 kDa,85 kDa

false

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Unknown

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : PIK3R1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : Jurkat whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab191606 observed at 90 kDa. Red - loading control, ab9484, observed at 37 kDa.

ab191606 was shown to specifically react with PIK3R1 when PIK3R1 knockout samples were used. Wild-type and PIK3R1 knockout samples were subjected to SDS-PAGE. ab191606 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606)

Predicted band size: 83 kDa

false

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Lab

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Lanes 1- 2 : Merged signal (red and green). Green - ab191606 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab191606 was shown to react with PI 3 Kinase p85 alpha in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265116 (knockout cell lysate ab257029) was used. Wild-type HeLa and PIK3R1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab191606 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

PIK3R1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human PIK3R1 (PI 3 Kinase p85 alpha) knockout HeLa cell line (<a href='/products/cell-lines/human-pik3r1-pi-3-kinase-p85-alpha-knockout-hela-cell-line-ab265116'>ab265116</a>)

Predicted band size: 83 kDa

Observed band size: 90 kDa

false

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Supplier Data

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Blocking/Dilution buffer : 5% NFDM/TBST.

The molecular weight observed is consistent with what have been described in the literatures (PMID : 8921377, 12649157).

All lanes:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution

Lane 1:

Human fetal liver lysate at 10 µg

Lane 2:

Human fetal heart lysate at 10 µg

Lane 3:

Human fetal kidney lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 83 kDa

Observed band size: 46 kDa,85 kDa

false

Exposure time: 3min

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Supplier Data

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Blocking/Dilution buffer : 5% NFDM/TBST.

Human PI3K p85 alpha full length recombinant protein contain aa1-724 with a His-Tag® (Cat#ab84769). Human PI3K p85 beta full length recombinant protein contain aa1-728 with a His-Tag® (Cat#ab125568).

All lanes:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/20000 dilution

Lane 1:

Human PI3K p85 alpha full length recombinant protein at 0.01 µg

Lane 2:

Human PI3K p85 beta full length recombinant protein at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 41 kDa,83 kDa

Observed band size: 55-60 kDa

false

Exposure time: 5s

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)
  • WB

Supplier Data

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (AB191606)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1-8 : 3 minutes; Lane 9-12 : 10 seconds.

The molecular weight observed is consistent with what have been described in the literatures (PMID : 8921377, 12649157).

All lanes:

Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) at 1/1000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Mouse heart lysate at 10 µg

Lane 3:

Mouse kidney lysate at 10 µg

Lane 4:

Mouse spleen lysate at 10 µg

Lane 5:

Rat brain lysate at 10 µg

Lane 6:

Rat heart lysate at 10 µg

Lane 7:

Rat kidney lysate at 10 µg

Lane 8:

Rat spleen lysate at 10 µg

Lane 9:

C6 (Rat glial tumor cell line) whole cell lysate at 10 µg

Lane 10:

RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg

Lane 11:

PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg

Lane 12:

NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 83 kDa

Observed band size: 46 kDa,85 kDa

false

関連する標識済み抗体及び組成の異なる製品 (4)

  • 578 PE

    PE Anti-PI 3 Kinase p85 alpha antibody [EPR18702]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-PI 3 Kinase p85 alpha antibody [EPR18702]

  • 660 APC

    APC Anti-PI 3 Kinase p85 alpha antibody [EPR18702]

  • Carrier free

    Anti-PI 3 Kinase p85 alpha antibody [EPR18702] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EPR18702

アイソタイプ

IgG

キャリアフリー

No

交差種

Mouse, Rat, Human, African green monkey

アプリケーション

IP, WB, ICC/IF, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/150", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/150", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "African green monkey": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Recombinant full length protein - Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

製品の詳細

What is this antibody validated in?
Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in African green monkey, Human, Mouse, Rat samples.

What is the molecular weight of PI 3 Kinase p85 alpha?
Anti-PI 3 Kinase p85 alpha [EPR18702] (ab191606) specifically detects a band for PI 3 Kinase p85 alpha (UniProt: Q63787) at a molecular weight of 84kDa.

Trusted by the scientific community
Anti-PI 3 Kinase p85 alpha [EPR18702] (ab191606) was first used in a scientific publication in 2016 and has been cited over 220 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (ab191606) has been confirmed by Western blot testing in PIK3R1 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EPR18702] also available for your convenience: ab191606, Carrier free - ab223792, APC - ab225369, PE - ab225370, Alexa Fluor® 488 - ab225371

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

PI 3 Kinase p85 alpha also known as PI3KR1 or phospho PI3K is a regulatory subunit of phosphoinositide 3-kinase (PI3K) that plays a fundamental role in various signaling pathways. The p85 protein has a molecular weight of approximately 85 kDa. This protein is widely expressed in many cell types facilitating essential cellular functions by forming a heterodimer with the class I PI3K catalytic subunit often implicated in regulating lipid signaling pathways.
Biological function summary

P85 alpha modulates intracellular signaling by interacting with other proteins in a complex formation with catalytic subunit p110. This interaction enables the initiation of downstream signaling cascades controlling cell growth proliferation and survival. PI 3 kinase activity mediated by p85 alpha is integral to cellular homeostasis and metabolism helping to execute cellular responses to a variety of growth factors and hormones.

Pathways

PI 3 Kinase p85 alpha integrates into two principal signaling networks: the PI3K-Akt and mTOR pathways. These pathways are instrumental for regulating anabolic processes and cell survival. The p85 form of PI3K interacts with additional proteins such as Akt and mTOR coordinating cellular energy balance promoting protein synthesis and inhibiting apoptosis. Through these interactions the protein ensures that cells respond accurately to nutritional and stress signals.

Alterations in PI 3 Kinase p85 alpha function have been linked to cancer and type 2 diabetes. Aberrant signaling involving PI3K-Akt-mTOR pathways due to mutations in PI3KR1 can contribute to tumor progression and chemoresistance. Moreover dysfunction of this pathway affects insulin signaling connecting p85 alpha to diabetic pathologies. Proteins such as IRS-1 (insulin receptor substrate 1) act alongside p85 alpha in mediating these disease-associated processes emphasizing its importance in maintaining physiological balance.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling (PubMed : 17626883, PubMed : 19805105, PubMed : 7518429). Modulates the cellular response to ER stress by promoting nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (PubMed : 20348923).
See full target information PIK3R1

文献 (388)

Recent publications for all applications. Explore the full list and refine your search

PloS one 20:e0332202 PubMed40991530

2025

Investigating the anti-osteosarcoma effects of Patchouli alcohol through protein network mapping and in vitro experiments.

Applications

Unspecified application

Species

Unspecified reactive species

Zeyu Zhan,He Pang,Hang Wu,Lijun Song,Bo Wei

Science advances 11:eadu5571 PubMed40961206

2025

Nanozyme eye drops for retinal barrier penetration and vasculopathy repair.

Applications

Unspecified application

Species

Unspecified reactive species

Bai Xue,Shuyu Wang,Tingting Wu,Lulu Wang,Xuejiao J Gao,Mengyuan Cao,Ming Tang,Yuxin Wan,Xiyun Yan,Wei Jiang,Bing Jiang

Journal of diabetes research 2025:9601959 PubMed40933728

2025

Myristoylated Cathelicidin-DM Fused With ANG1-7: A Novel Self-Assembling Antimicrobial Peptide for the Treatment and Mechanism of Diabetic Infected Wounds.

Applications

Unspecified application

Species

Unspecified reactive species

Rongqin Feng,Peng Wang,Li Fan,He Lu,Danna Yao,Panpan Sun,Zhonghua Liu,Fu Han,Xiaozhi Bai,Xuekang Yang,Juntao Han

Open medicine (Warsaw, Poland) 20:20251261 PubMed40918151

2025

CircASH1L-mediated tumor progression in triple-negative breast cancer: PI3K/AKT pathway mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Haiyan Liu,Jiaming Wu,Jin Gong,Jing Zhu,Jie Liu,Xiaoqing Chen,Shaohua Qu,Jintao Chen,Zhisheng Zhou,Xulong Fan

Acta pharmaceutica Sinica. B 15:4248-4264 PubMed40893673

2025

Artificial mesenchymal stem cell extracellular vesicles enhanced ischemic stroke treatment through targeted remodeling brain microvascular endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shengnan Li,Wei Lv,Jiangna Xu,Jiaqing Yin,Yuqin Chen,Linfeng Liu,Xiang Cao,Wenjing Li,Zhen Li,Hua Chen,Hongliang Xin

Frontiers in medicine 12:1614592 PubMed40809438

2025

Mechanism of action of decitabine in treating acute lymphoblastic leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohui Gao,Hui Zeng,Fei Sun,Xiaoyan Zhao,Haibing Wu,Minchao Yan,Yuan Li,Qinyan Fu,Gang Zhang

Cell biochemistry and function 43:e70108 PubMed40770889

2025

Osteoking Ameliorates Type 2 Diabetes Osteoporosis by Enhancing Osteoblast Differentiation via PI3K/AKT/GSK-3β Pathway Activation.

Applications

Unspecified application

Species

Unspecified reactive species

Rong Li,Jiangli Lu,Peijin Wang,Yulan Zhao,Yi Yang,Jianlin Jiao,Zhongyi Qian,Limei Wang,Hong Zheng

Pharmaceuticals (Basel, Switzerland) 18: PubMed40732297

2025

Isoliensinine Induces Ferroptosis in Urothelial Carcinoma Cells via the PI3K/AKT/HIF-1α Axis: Molecular Evidence from Next-Generation Sequencing.

Applications

Unspecified application

Species

Unspecified reactive species

Yun-Chen Li,Hsuan-En Huang,Chia-Ying Yu,Ya-Chuan Chang,Shu-Yu Lin,Shao-Chuan Wang,Wen-Wei Sung

mSystems 10:e0014825 PubMed40693815

2025

Gut-derived exerts anti-cancer effects on colorectal cancer by modulating PDPN-CLEC-2 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaojuan Yang,Miao Liu,Ting Wang,Xinjuan Ma,Zhirong Guan,Bin Ma,Xiangguo Duan,Chunxia Su

Nature communications 16:6389 PubMed40640139

2025

Targeting modulation of the choroid plexus blood-CSF barrier and CSF hypersecretion via lipid nanoparticle-mediated co-delivery of siRNA and resveratrol.

Applications

Unspecified application

Species

Unspecified reactive species

Qiguang Wang,Xue Xia,Huan Zhang,Yue Li,Lei Zhu,Yulong Shi,Yuzhao Tang,Jian Cheng,Xuhui Hui,Huile Gao
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com